Syros Pharmaceuticals IPO Research Information

Syros Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Syros Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Syros Pharmaceuticals	SYRS - NASDAQ	$14.00-$16.00	$12.50	$15.00	4 million	6/30/2016
Underwriter(s): Cowen & Co., Piper Jaffray
Co-Manager(s): JMP Securities, Wedbush PacGrow
Industry: Health Care
Filing(s): Filed 2016-06-03 Terms Added 2016-06-20

Syros Pharmaceuticals Quote & Chart - Click for current quote - SYRS

About Syros Pharmaceuticals (adapted from Syros Pharmaceuticals prospectus):
They are a biopharmaceutical company pioneering an understanding of the region of the genome controlling the activation and repression of genes.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "SYRS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.